This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Institut Pasteur Korea and Proteros establish a new collaboration

May 24th, 2011

Martinsried, Germany, May 24, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K. Under this collaboration Proteros will apply its know-how, experience of structural analysis and its proprietary X-ray crystallography platform to support IP-K's mission to develop therapeutics for infectious diseases.

Cony D'Cruz, Chief Business Officer of Proteros, stated, "Institut Pasteur Korea is a world class translational research institute, renowned as a centre of excellence in biomedical research and technology development with a clear focus on infectious and neglected disease. We welcome the opportunity for Proteros to contribute to these efforts."

Dr. Michel Liuzzi, Director, Early Discovery Program at IP-K, added "We are very pleased with the expertise and know-how of Proteros in providing timely X-ray crystallography support to our in-house drug discovery projects and we look forward to continue collaborating with Proteros in the future."

Provided by Institut Pasteur Korea

Citation: Institut Pasteur Korea and Proteros establish a new collaboration (2011, May 24) retrieved 13 August 2026 from https://sciencex.com/wire-news/67687701/institut-pasteur-korea-and-proteros-establish-a-new-collaboratio.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.